Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964834 · ClinicalTrials.gov registry record · Phase 1
Ph1 Study of Valortim and Doxycycline in Humans
A Phase 1 study, sponsored by PharmAthene.
- Terminated
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00964834: Clinical Trial Phase 1 study, sponsored by PharmAthene.
NCT00964834 is a Phase 1 study that was terminated before completion, run by PharmAthene. The registered enrollment target is 24 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00964834, a Phase 1 study, was terminated before completion, sponsored by PharmAthene.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability of short-term dosing of IV doxycycline when administered concomitantly with IV Valortim in normal healthy human subjects.
Interventions
- DRUG Doxycycline and Valortim
- DRUG Placebo Antibiotic and Valortim
- DRUG Placebo Antibiotic and Placebo Valortim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
Why NCT00964834 stopped before completion
NCT00964834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 3 interventions - of which Doxycycline and Valortim is the first listed.
NCT00964834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00964834 about?
NCT00964834 is a clinical study titled "Ph1 Study of Valortim and Doxycycline in Humans". The purpose of this study is to evaluate the safety and tolerability of short-term dosing of IV doxycycline when administered concomitantly with IV Valortim in normal healthy human subjects.
What is the current status of trial NCT00964834?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2009-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00964834?
The interventions under investigation include: Doxycycline and Valortim (DRUG), Placebo Antibiotic and Valortim (DRUG), Placebo Antibiotic and Placebo Valortim (DRUG).
Who is sponsoring clinical trial NCT00964834?
This trial is sponsored by PharmAthene, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00964834's enrollment target sits among peer trials
24 1520th of 2000 higher than 405 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia